BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tan X, Johnson S. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'. Anaerobe 2019;60:102092. [PMID: 31472233 DOI: 10.1016/j.anaerobe.2019.102092] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Rupnik M, Janezic S. Clostridioides (Clostridium) difficile - Interesting and difficult. Anaerobe 2019;60:102124. [PMID: 31839124 DOI: 10.1016/j.anaerobe.2019.102124] [Reference Citation Analysis]
2 Żebrowska P, Łaczmańska I, Łaczmański Ł. Future Directions in Reducing Gastrointestinal Disorders in Children With ASD Using Fecal Microbiota Transplantation. Front Cell Infect Microbiol 2021;11:630052. [PMID: 33718277 DOI: 10.3389/fcimb.2021.630052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li X, Kang Y, Huang Y, Xiao Y, Song L, Lu S, Ren Z. A strain of Bacteroides thetaiotaomicron attenuates colonization of Clostridioides difficile and affects intestinal microbiota and bile acids profile in a mouse model. Biomed Pharmacother 2021;137:111290. [PMID: 33508620 DOI: 10.1016/j.biopha.2021.111290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hollingshead C, Ciricillo J, Kammeyer J. Ethical Implications of the Fecal Microbiota Transplantation: Disclosure of a False-Positive HIV Test. Case Rep Infect Dis 2021;2021:6696542. [PMID: 34912583 DOI: 10.1155/2021/6696542] [Reference Citation Analysis]
5 Henson MA. Computational modeling of the gut microbiota reveals putative metabolic mechanisms of recurrent Clostridioides difficile infection. PLoS Comput Biol 2021;17:e1008782. [PMID: 33617526 DOI: 10.1371/journal.pcbi.1008782] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Honarpisheh P, Bryan RM, McCullough LD. Aging Microbiota-Gut-Brain Axis in Stroke Risk and Outcome. Circ Res 2022;130:1112-44. [PMID: 35420913 DOI: 10.1161/CIRCRESAHA.122.319983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Nana T, Moore C, Boyles T, Brink AJ, Cleghorn J, Devenish LM, du Toit B, Fredericks ES, Lekalakala-Mokaba MR, Maluleka C, Rajabally MN, Reubenson G, Shuping L, Swart K, Swe Han KS, Wadula J, Wojno J, Lowman W. South African Society of Clinical Microbiology Clostridioides difficile infection diagnosis, management and infection prevention and control guideline. S Afr J Infect Dis 2020;35:219. [PMID: 34485483 DOI: 10.4102/sajid.v35i1.219] [Reference Citation Analysis]
8 Auchtung JM, Preisner EC, Collins J, Lerma AI, Britton RA. Identification of Simplified Microbial Communities That Inhibit Clostridioides difficile Infection through Dilution/Extinction. mSphere 2020;5:e00387-20. [PMID: 32727857 DOI: 10.1128/mSphere.00387-20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
9 Liu H, Wang HH. Impact of Microbiota Transplant on Resistome of Gut Microbiota in Gnotobiotic Piglets and Human Subjects. Front Microbiol 2020;11:932. [PMID: 32508773 DOI: 10.3389/fmicb.2020.00932] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Valeri F, dos Santos Guilherme M, He F, Stoye NM, Schwiertz A, Endres K. Impact of the Age of Cecal Material Transfer Donors on Alzheimer’s Disease Pathology in 5xFAD Mice. Microorganisms 2021;9:2548. [DOI: 10.3390/microorganisms9122548] [Reference Citation Analysis]
11 Liwinski T, Elinav E. Harnessing the microbiota for therapeutic purposes. Am J Transplant 2020;20:1482-8. [PMID: 31858698 DOI: 10.1111/ajt.15753] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
12 Principi N, Gnocchi M, Gagliardi M, Argentiero A, Neglia C, Esposito S. Prevention of Clostridium difficile Infection and Associated Diarrhea: An Unsolved Problem. Microorganisms 2020;8:E1640. [PMID: 33114040 DOI: 10.3390/microorganisms8111640] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Youngster I. Another step in the journey - from feces to regulated microbial therapeutics. Clin Infect Dis 2020:ciaa1435. [PMID: 32961549 DOI: 10.1093/cid/ciaa1435] [Reference Citation Analysis]
14 Fettucciari K, Marconi P, Marchegiani A, Fruganti A, Spaterna A, Bassotti G. Invisible steps for a global endemy: molecular strategies adopted by Clostridioides difficile. Therap Adv Gastroenterol 2021;14:17562848211032797. [PMID: 34413901 DOI: 10.1177/17562848211032797] [Reference Citation Analysis]